T
Tak-Lun Que
Researcher at Tuen Mun Hospital
Publications - 99
Citations - 5964
Tak-Lun Que is an academic researcher from Tuen Mun Hospital. The author has contributed to research in topics: Streptococcus pneumoniae & Methicillin-resistant Staphylococcus aureus. The author has an hindex of 34, co-authored 98 publications receiving 5366 citations. Previous affiliations of Tak-Lun Que include Yan Chai Hospital & University of Hong Kong.
Papers
More filters
Journal ArticleDOI
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
Ivan Hung,Kwok Cheung Lung,Eugene Yuk Keung Tso,Raymond W. Liu,Tom Wai-Hin Chung,Man Yee Chu,Yuk Yung Ng,Jenny Lo,Jacky Chan,Anthony Raymond Tam,Hoi-Ping Shum,Veronica L. Chan,Alan Ka Lun Wu,Kit Man Sin,Wai Shing Leung,Wai Lam Law,David Christopher Lung,Simon Yung Wa Sin,Pauline Yeung,Cyril C. Y. Yip,Ricky Ruiqi Zhang,Agnes Yim Fong Fung,Erica Yuen Wing Yan,Kit-Hang Leung,Jonathan Daniel Ip,Allen Wing-Ho Chu,Wan Mui Chan,Anthony Chin-Ki Ng,Rodney A. Lee,Kitty S. C. Fung,Alwin Wt Yeung,Tak Chiu Wu,Johnny W.M. Chan,Wing Wah Yan,Wai-Ming Chan,Jasper Fuk-Woo Chan,Albert K. W. Lie,Owen Tak Yin Tsang,Vincent C.C. Cheng,Tak-Lun Que,Chak Sing Lau,Kwok-Hung Chan,Kelvin K. W. To,Kwok-Yung Yuen +43 more
TL;DR: Yu et al. as mentioned in this paper assessed the efficacy and safety of combined interferon beta-1b, lopinavir-ritonavir, and ribavirin for treating patients with COVID-19.
Journal ArticleDOI
Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.
Kwok-Yung Yuen,Paul K.S. Chan,Malik Peiris,D. N. C. Tsang,Tak-Lun Que,Kennedy F. Shortridge,P. T. Cheung,W. K. To,E. T. F. Ho,R. Sung,A. F. B. Cheng +10 more
TL;DR: Avian Influenza A H5N1 virus causes human influenza-like illness with a high rate of complications in adults admitted to hospital, and rapid H5-subtype-specific laboratory diagnosis can be made by RT-PCR applied directly to clinical specimens.
Journal ArticleDOI
Emergence of Fluoroquinolone Resistance among Multiply Resistant Strains of Streptococcus pneumoniae in Hong Kong
TL;DR: The MICs of 17 antimicrobial agents for 181 Streptococcus pneumoniae strains were determined by the E-test and 69.1% were penicillin resistant (MIC > 0.06 μg/ml).
Journal ArticleDOI
Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000
Pak-Leung Ho,R. W. H. Yung,Dominic N.C. Tsang,Tak-Lun Que,M. Ho,Wkw Seto,Tak Keung Ng,Wing-Cheong Yam,Wilson W. Ng +8 more
TL;DR: The prevalence of fluoroquinolone non-susceptibility (levofloxacin MIC > or = 4 mg/L) was 13.3%, but increased to 27.3% among the penicillin-resistant isolates.
Journal ArticleDOI
Usefulness of the MicroSeq 500 16S ribosomal DNA-based bacterial identification system for identification of clinically significant bacterial isolates with ambiguous biochemical profiles
Patrick C. Y. Woo,Kenneth H. L. Ng,Susanna K. P. Lau,Kam-Tong Yip,Ami M. Y. Fung,Kit-Wah Leung,Dorothy M. W. Tam,Tak-Lun Que,Kwok-Yung Yuen +8 more
TL;DR: The database of the MicroSeq 500 16S rDNA-based bacterial identification system has to be expanded in order to encompass the rarely encountered bacterial species and achieve better accuracy in bacterial identification.